2020
DOI: 10.3390/v12121437
|View full text |Cite
|
Sign up to set email alerts
|

Characterization and Diversity of 243 Complete Human Papillomavirus Genomes in Cervical Swabs Using Next Generation Sequencing

Abstract: In recent years, next generation sequencing (NGS) technology has been widely used for the discovery of novel human papillomavirus (HPV) genotypes, variant characterization and genotyping. Here, we compared the analytical performance of NGS with a commercial PCR-based assay (Anyplex II HPV28) in cervical samples of 744 women. Overall, HPV positivity was 50.2% by the Anyplex and 45.5% by the NGS. With the NGS, we detected 25 genotypes covered by Anyplex and 41 additional genotypes. Agreement between the two meth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(13 citation statements)
references
References 58 publications
1
12
0
Order By: Relevance
“…Furthermore, testing the workflows on a portable notebook computer endorses software performance efficiency for benchtop or fieldwork, as well as, in austere clinical settings. In contradistinction, a recent publication used nine bioinformatics software for HPV de novo assembly, genotyping, phylogenetic analysis, and visualization (Bowtie2, SPAdes, VAPiD, MAFFT, RAxML, MEGA7, iTOL5.3, Dendroscope3, and R) [ 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 ]. In recent years, the list of superb bioinformatics software has lengthened considerably and is welcomed by the research community [ 18 , 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, testing the workflows on a portable notebook computer endorses software performance efficiency for benchtop or fieldwork, as well as, in austere clinical settings. In contradistinction, a recent publication used nine bioinformatics software for HPV de novo assembly, genotyping, phylogenetic analysis, and visualization (Bowtie2, SPAdes, VAPiD, MAFFT, RAxML, MEGA7, iTOL5.3, Dendroscope3, and R) [ 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 ]. In recent years, the list of superb bioinformatics software has lengthened considerably and is welcomed by the research community [ 18 , 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, testing the workflows on a portable notebook computer endorses software performance efficiency for benchtop or fieldwork, as well as, in austere clinical settings. In contradistinction, a recent publication used nine bioinformatics software for HPV de novo assembly, genotyping, phylogenetic analysis, and visualization (Bowtie2, SPAdes, VAPiD, MAFFT, RAxML, MEGA7, iTOL5.3, Dendro-scope3, and R) [23]. In recent years, the list of superb bioinformatics software has lengthened considerably and is welcomed by the research community [18,24].…”
Section: Discussionmentioning
confidence: 99%
“…HPV-28 has been widely used for HPV genotyping in clinical and epidemiological studies [10][11][12][13][14][15] and has been evaluated in comparative studies against various genotyping assays. 12,[16][17][18][19][20][21] Anyplex HPV II HR detection assay has been validated using the international Valgent framework 8 and was shown to meet the international consensus guideline for HPV test requirements. 22 HPV-28 has been previously compared with LA-HPV using cervical samples, [18][19][20] but to our knowledge, these assays have not been compared using other specimens from the anogenital tract nor among people living with HIV.…”
Section: Introductionmentioning
confidence: 99%
“…HPV‐28 is thus a suitable alternative to LA‐HPV for HPV genotyping. HPV‐28 has been widely used for HPV genotyping in clinical and epidemiological studies 10–15 and has been evaluated in comparative studies against various genotyping assays 12,16–21 . Anyplex HPV II HR detection assay has been validated using the international Valgent framework 8 and was shown to meet the international consensus guideline for HPV test requirements 22 …”
Section: Introductionmentioning
confidence: 99%